Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: Reversal by the anti-angiogenic agent SU6668

American Journal of Pathology

Volumn 160, Issue 6, 2002, Pages 2219-2230

  Zhang, Hong ^a   Issekutz, Andrew C ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; CADHERIN; CD31 ANTIGEN; COMPLEMENT COMPONENT C5A; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBROBLAST GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN TYROSINE KINASE INHIBITOR; RANTES; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MONOCYTE; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 0036084184     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61169-8     Document Type: Article

References (62)

1. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
2. Endothelial cells in physiology and in the pathophysiology of vascular disorders
3. Angiogenesis: A dynamic balance of stimulators and inhibitors
4. Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression
5. Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
6. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
7. Capillary endothelial cells express basic fibroblast growth factor, A mitogen that promotes their own growth
8. Proinflammatory mediators stimulate neutrophil-directed angiogenesis
9. Cytokines modulate integrin alpha(v)-beta(3)-mediated human endothelial cell adhesion and calcium signaling
10. Intercellular adhesion molecule-1
11. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity
12. Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow
13. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1
14. Role of ICAM-1 and ICAM-2 and alternate CD11/CD18 ligands in neutrophil transendothelial migration
15. Leukocyte-endothelial cell interactions
16. Two-step model of leukocyte-endothelial cell interaction in inflammation: Distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo
17. Integrins, angiogenesis and vascular cell survival
18. Leukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin, and beta2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels
19. Vascular endothelial growth factor and basic fibroblast growth factor evaluation in blood serum of patients with hormonally active and inactive adrenal gland tumours
20. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours
21. Angiogenesis modulates the tumour immune response
22. Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma
23. Elevated levels of angiogenic cytokines in the plasma of cancer patients
24. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: The role of angiogenic factors
25. Growth factor regulation of neutrophil-endothelial cell interactions
26. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors
27. VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes
28. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium
29. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
30. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: Involvement of distinct and unique mechanisms
31. Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma
32. Effect of a new monoclonal antibody, TA-2, that inhibits lymphocyte adherence to cytokine stimulated endothelium in the rat
33. Chemokine production and adhesion molecule expression by neural cells exposed to IL-1, TNF alpha and interferon gamma
34. Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration
35. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium
36. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment
37. Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro
38. Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction
39. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow
40. Serum basic fibroblast growth factor in men with and without prostate carcinoma
41. Angiogenin, interleukins, and growth-factor levels in serum of patients with ovarian cancer: Correlation with angiogenesis
42. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
43. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway
44. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells
45. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
46. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
47. Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis
48. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis
49. Effect of FGF-1 and FGF-2 on VEGF binding to human umbilical vein endothelial cells
50. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma
51. Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: A cancer and leukemia group B study
52. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: Endothelial cell interactions
53. IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1 alpha, RANTES, and PAF but inhibits migration to MCP-1: A regulatory role for endothelium-derived MCP-1
54. Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 (MCP-1) in autocrine-activated endothelial cells
55. Effects of neoplasms on inflammation: Depression of macrophage accumulation after tumor implantation
56. Defective monocyte killing in patients with malignancies and restoration of function during chemotherapy
57. Human monocyte killing of tumor cells: Contribution of an extracellular cytotoxin
58. Angiogenesis: Regulators and clinical applications
59. Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms
60. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers
61. Transcriptional regulation of endothelial cell adhesion molecules: A dominant role for NF-kappa B
62. NF-kappa B: A lesson in family values